Increase of number of shares and votes in Vicore Pharma

2022-12-30 | Regulatory

Stockholm, December 30, 2022– Vicore Pharma Holding AB (publ) (“Vicore” or the “company”)’s registered share capital and number of outstanding shares and votes have increased during the month of December 2022.

As previously announced, the company’s board of directors resolved on a directed share issue of 10,000,000 shares at a subscription price of SEK 20.00 per share on December 8, 2022. Through the share issue, Vicore received issue proceeds of 200 MSEK before issue costs.

As of today, the total number of registered and outstanding shares and votes of Vicore amounts to 81,847,979. Furthermore, the registered share capital amounts to SEK 40,923,989.10.

For further information, please contact:
Carl-Johan Dalsgaard, CEO, tel: +46 70 975 98 63,  
Hans Jeppsson, CFO, tel: +46 70 553 14 65,

This information is information that Vicore Pharma Holding AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact persons set out above, on December 30, 2022, at 09:00 CEST.